Biological
Dendritic Cell clinical trials
- studies test it
- 48
- open now
- 4
- in phase 3
- 2
- first study started
- 2000
Keep track of what changes. Save the Dendritic Cell studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
47 studies that test it; most in 2014 (5)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 26
- Phase 2
- 26
- Phase 3
- 2
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 45
Radboud University Medical Center (3) · University Hospital, Ghent (2) · Clinica Universidad de Navarra, Universidad de Navarra (2) · Affiliated Hospital to Academy of Military Medical Sciences (2) · Northwest Biotherapeutics (2) · Beijing Tiantan Hospital (1) · Chang Gung Memorial Hospital (1) · PT. JES Kasih Nusantara Sejahterah (1)
Often tested with
Tested in the same studies.
Cytokine-Induced Killer Cells (2) · Picibanil (2) · Dasatinib (1) · Autologous Tumor Cells (1) · Bevacizumab (1) · Interleukin-2 (1) · Cyclophosphamide (1) · Docetaxel (1)
Studies
Open first, then newest update. How each study uses Dendritic Cell is read from its arms, and is right about nine times in ten.
Testing it · 48
- Preventive Dendritic Cell Vaccination for Lynch SyndromeNot yet recruitingPhase 1/2Radboud University Medical CenterNCT07412197Written as DC vaccination
- A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid TumorRecruitingNot applicableFudan UniversityNCT06682117Written as DC Vaccine
- Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid LeukemiaRecruitingNot applicableAffiliated Hospital to Academy of Military Medical SciencesNCT05000801Written as DC vaccine
- Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic SyndromeRecruitingPhase 1Affiliated Hospital to Academy of Military Medical SciencesNCT04999943Written as DC vaccine
- Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade GliomasActive, not recruitingPhase 1Beijing Tiantan HospitalNCT06253234Written as personalized dendritic cell injection ZSNeo-DC1.1
- Dendritic Cell-immunotherapy for Advanced Hepatocellular CarcinomaActive, not recruitingPhase 2Chang Gung Memorial HospitalNCT07726329Written as dendritic cells
- Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney DiseaseActive, not recruitingPhase 1/2PT. JES Kasih Nusantara SejahterahNCT06866158Written as Dendritic cell immunotherapy
- MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung CancerCompletedPhase 1University Hospital, GhentNCT04078269Written as Dendritic cell immunotherapy
- Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSIActive, not recruitingPhase 1/2Radboud University Medical CenterNCT01885702Written as DC vaccination
- Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed GlioblastomaActive, not recruitingPhase 2Heinrich-Heine University, DuesseldorfNCT03395587Written as Autologous, tumor lysate-loaded, mature dendritic cells (DC)
- DC Vaccine in Colorectal CancerTerminatedPhase 1University of PennsylvaniaNCT03730948Written as DC vaccine
- Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in RemissionActive, not recruitingPhase 2Zwi BernemanNCT01686334Written as DC vaccine
- Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK ImmunotherapyCompletedNot applicableCapital Medical UniversityNCT01906632Written as DC-CIK Immunotherapy
- DC Vaccination in CMLTerminatedPhase 1/2Charite University, Berlin, GermanyNCT02543749Written as DC vaccine
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain CancerStatus unknownPhase 3Northwest BiotherapeuticsNCT00045968Written as Dendritic cell immunotherapy
- Dendritic Cell Vaccination With Standard Postoperative Chemotherapy for the Treatment of Adult Ovarian CancerStatus unknownPhase 1West China Second University HospitalNCT05270720Written as dendritic cell
- Ovarian Dendritic Cell Vaccine TrialStatus unknownPhase 2Loyola UniversityNCT00703105Written as DC vaccination
- MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung CancerStatus unknownPhase 1University Hospital, GhentNCT04082182Written as Dendritic cell immunotherapy
- Treatment of Recurrent Bladder Cancer With Dendritic CellsCompletedPhase 2Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusNCT04184232Written as Dendritic cells
- Study of DC Vaccination Against GlioblastomaStatus unknownPhase 2Huashan HospitalNCT01567202Written as DC vaccination
See all 48 studies that test Dendritic Cell →
Given in every arm · 9 — Dendritic Cell is usual care beside what is tested
- Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural MesotheliomaRecruitingPhase 1/2University Hospital, AntwerpNCT05765084Written as Dendritic cell vaccination
- Dendritic Cell Vaccine for Children and Adults With SarcomaCompletedPhase 1Macarena De La Fuente, MDNCT01803152Written as Dendritic Cells Vaccine
- Combination of Immunotherapy and Hyperthermia in Advanced Malignant MesotheliomaTerminatedPhase 1/2Capital Medical UniversityNCT03393858Written as DC-CIK Immunotherapy
- A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma RecurrenceCompletedPhase 2Nina BhardwajNCT02334735Written as DC Vaccine
- Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer TreatmentStatus unknownPhase 1/2The Second Hospital of Shandong UniversityNCT04567069Written as DC vaccine
- Nivolumab With DC Vaccines for Recurrent Brain TumorsCompletedPhase 1Gary Archer Ph.D.NCT02529072Written as DC
- A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic AdenocarcinomaCompletedPhase 1Medical University of South CarolinaNCT01677962Written as dendritic cell
- Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast CancerActive, not recruitingPhase 2The First People's Hospital of ChangzhouNCT02491697Written as DC-CIK Immunotherapy
- Dendritic Cell Based Therapy for Breast Cancer PatientsWithdrawnPhase 2Inge Marie SvaneNCT00935558Written as DC vaccine